Search Results for "pseudoephedrine"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for pseudoephedrine. Results 21 to 23 of 23 total matches.
Rasagiline (Azilect) for Parkinson's Disease
The Medical Letter on Drugs and Therapeutics • Dec 04, 2006 (Issue 1249)
, ephedrine, phenylephrine, pseudoephedrine (Sudafed, and others)
Other drugs: cyclobenzaprine (Flexeril ...
Rasagiline (Azilect - Teva), a monoamine oxidase-type B (MAO-B) inhibitor, was recently approved by the FDA for once-daily oral treatment of Parkinson's disease (PD). It can be taken alone for treatment of early disease or with levodopa/carbidopa (Sinemet, and others) for advanced disease. Selegiline (Eldepryl, and others), the first MAO-B inhibitor marketed in the US, has been available since 1988; a new lower-dose disintegrating tablet (Zelapar) was recently approved.
Comparison Table: Drugs for Parkinson's Disease (online only)
The Medical Letter on Drugs and Therapeutics • Feb 22, 2021 (Issue 1618)
,
or sympathomimetic amines such as pseudoephedrine
can result in severe hypertension
iCoadministration ...
View the Comparison Table: Drugs for Parkinson's Disease
Drugs for Parkinson's Disease
The Medical Letter on Drugs and Therapeutics • Feb 22, 2021 (Issue 1618)
such as
pseudoephedrine and an MAO-B inhibitor can result in
severe hypertension.
Unlike MAO-A inhibitors used ...
The motor symptoms of Parkinson's disease (PD) are
caused primarily by degeneration of dopaminergic
neurons in the substantia nigra. The nonmotor symptoms
of the disease are thought to be caused by degeneration of
other neurotransmitter systems. No disease-modifying
drugs are available for treatment of PD.